Prof John Dillon is Professor of Hepatology and Gastroenterology and a principle investigator, in the Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, based at Ninewells hospital, Dundee. He is also an Honorary Consultant with NHS Tayside, leading a busy general hepatology service and a research group. He is Vice President for Hepatology of the British Society of Gastroenterology and was President of the Scottish Society of Gastroenterology. He graduated in medicine from St Georges Hospital Medical School, University of London, and subsequently gained his MD based on research performed at the University of Edinburgh while a lecturer in Gastroenterology and Hepatology.
His award-winning research interests include; new pathways of care for patients with abnormal LFTs, for people infected with HCV, new therapies for HCV infection, as well as novel diagnostics and treatments for NAFLD. His research activities stretch from the bench to the bedside and out into the community. He has published over 200 peer reviewed original research papers. The impact of his research work includes the Tayside region of Scotland reaching WHO HCV elimination targets in 2020 and the deployment of iLFT into routine NHS care. He chairs the Scottish HCV Action Plan Clinical Leads Group, is a member of the Scottish Government’s Ministerial advisory board for Blood Borne viruses and sexual health. He previously twice led the development group of the UK consensus guidelines for HCV and has chaired the Hepatitis C SIGN guideline development group and it revisions. He Chaired the SHAAP group that produced the recent “Alcohol-related liver disease: guidance for good practice” documents. He has delivered over 200 international lectures on liver disease
